Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linezolid continuous infusion dosing optimization in critically ill ICU patients
2015-002987-17Phase 3Active
- Sponsor
- Helena Barrasa
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of linezolid in bacterial disease (2 arms), sponsored by Helena Barrasa. Primary endpoint: Primary efficacy comparison. Started Nov 2015; status: active.
02
Drugs
linezolid
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2015-002987-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002987-17.